| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and ribavirin in chronic hepatitis C genotype 4A randomized trial and quality of life analysis. | Liver Int | 2011 | 0.84 |
| 2 | Risk of non-melanoma skin cancer in autoimmune hepatitis. | Dig Dis Sci | 2010 | 0.76 |